{
    "clinical_study": {
        "@rank": "30141", 
        "acronym": "ACS1", 
        "arm_group": {
            "arm_group_label": "Catheter placed", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "This is a single centre, non-randomised, baseline controlled, prospective pilot clinical\n      trial to be undertaken at Rotherham General Hospital, Rotherham, UK.\n\n      The study will examine the safety and performance of a new urinary catheter, the Alternative\n      Catheter System (ACS) (Alternative Urological Catheter Systems Ltd (AUCS), Bristol, UK)\n      which has been developed to reduce the morbidity of long-term catheterisation and the\n      acknowledged deficiencies of the conventional Foley urinary catheter."
        }, 
        "brief_title": "Feasibility Assessment of ACS Catheter", 
        "completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Urological", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Male or female, at least 18 years of age.\n\n          2. Patient or authorised representative must be able to comprehend and sign the Informed\n             Consent Form prior to enrolment in the study.\n\n          3. Capable of using a catheter valve to empty the bladder and able to communicate their\n             experience with the system OR who has a carer able to fulfil these tasks.\n\n          4. Fitted with a suprapubic catheter (at least 2 weeks post insertion).\n\n          5. Ability to attend out-patient clinic at regular intervals throughout the study and\n             able to participate for a maximum of 8 weeks.\n\n          6. History of catheter blockages, bypassing or episodes of pyrexia and bacteraemia in\n             the last 2 months.\n\n        Exclusion Criteria:\n\n          1. <18 years of age.\n\n          2. Pregnant or lactating females.\n\n          3. History of catheter associated septicaemia in the past month.\n\n          4. Evidence of current systemic infection.\n\n          5. Bladder pathology such as a tumour or stone >0.5cm as determined by cystoscopy.\n\n          6. Flaccid bladder.\n\n          7. BMI>35.\n\n          8. Current participation in another device or drug study.\n\n          9. Unwilling or unable to provide informed consent."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "6", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 7, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01960517", 
            "org_study_id": "AUCS/2013/ACS01"
        }, 
        "intervention": {
            "arm_group_label": "Catheter placed", 
            "intervention_name": "ACS Catheter", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Urinary", 
            "Incontinence", 
            "Catheter"
        ], 
        "lastchanged_date": "October 9, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Rotherham", 
                    "country": "United Kingdom", 
                    "zip": "S60 2UD"
                }, 
                "name": "Rotherham NHS Foundation Trust, Rotherham General Hospital"
            }, 
            "investigator": [
                {
                    "last_name": "Mr Isa Edhem, MB BS", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Ms Joanne Magnall", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "United Kingdom"
        }, 
        "number_of_arms": "1", 
        "official_title": "A Feasibility Assessment of a New Urinary Catheter: The Alternative Catheter System ACS)", 
        "overall_official": {
            "affiliation": "Rotherham NHS Foundation Trust", 
            "last_name": "Mr Isa Idhem", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United Kingdom: Medicines and Healthcare Products Regulatory Agency", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2/Phase 3", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Retention of the ACS catheter", 
            "safety_issue": "No", 
            "time_frame": "12 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01960517"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Alternative Urological Catheter Systems Ltd.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Alternative Urological Catheter Systems Ltd.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}